HCA Healthcare (NYSE:HCA) Cut to “Neutral” at The Goldman Sachs Group

The Goldman Sachs Group lowered shares of HCA Healthcare (NYSE:HCA – Free Report) from a buy rating to a neutral rating in a research note published on Monday, MarketBeat reports. The Goldman Sachs Group currently has $271.00 price target on the stock. A number of other analysts also recently weighed in on HCA. Stephens reissued […]

Leave a Reply

Your email address will not be published.

Previous post Marathon Oil (NYSE:MRO) Rating Reiterated by Morgan Stanley
Next post Thermo Fisher Scientific (NYSE:TMO) Price Target Increased to $575.00 by Analysts at Citigroup